Lupin Insists It Will Rebuild Quality Reputation Following Latest FDA Action

Indian Firm Moves On From Warning Letter As Goa Plant Gets VAI Status

Lupin says it is rebuilding its reputation for quality and compliance after the US FDA awarded VAI status to a manufacturing facility in Goa that was hit by a warning letter back in 2017.

Quality Word Letter Blocks
Lupin wants to rebuild a reputation for quality • Source: Alamy

Lupin has celebrated the outcome of a US Food and Drug Administration inspection of its warning letter-stricken Goa manufacturing facility, after the agency awarded the plant “voluntary action indicated” status.

The agency defines VAI status as meaning that “objectionable conditions or practices were found but the agency is not prepared...

More from Manufacturing

More from Business